Lois S. Weisman

Lois S. Weisman

Auto-generated profile, based on publicly available information

Lois S. Weisman

Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2007 in Nature
Verified
Journal Article
Closed access
PDF file
CCClement Y. Chow
Clement Y. Chow
YZYanling Zhang
Yanling Zhang
JDJames J. Dowling
James J. Dowling
NJNatsuko Jin
Natsuko Jin
MAMaja Adamska
Maja Adamska
MMMiriam H. Meisler
Miriam H. Meisler

1 January 2009 in The American Journal of Human Genetics
Verified
Journal Article
Open access
CCClement Y. Chow
Clement Y. Chow
JLJohn E. Landers
John E. Landers
SBSarah K. Bergren
Sarah K. Bergren
PSPeter C. Sapp
Peter C. Sapp
AGAdrienne E. Grant
Adrienne E. Grant
MMMiriam H. Meisler
Miriam H. Meisler
Mutations of the lipid phosphatase FIG4 that regulates PI(3,5)P(2) are responsible for the recessive peripheral-nerve disorder CMT4J. We now describe nonsynonymous variants of FIG4 in 2% (9/473) of patients with amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS). Heterozygosity for a deleterious allele of FIG4 appears to be a risk factor for ALS and PLS, extending the list of known ALS genes and increasing the clinical spectrum of FIG4-related diseases.

1 September 2013 in Developmental Cell
Verified
Journal Article
Closed access
MSMohammad Samie
Mohammad Samie
XWXiang Wang
Xiang Wang
XZXiaoli Zhang
Xiaoli Zhang
AGAndrew Goschka
Andrew Goschka
XLXinran Li
Xinran Li
HXHaoxing Xu
Haoxing Xu

9 October 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
SZSergey N. Zolov
Sergey N. Zolov
Dave  BridgesDave Bridges
Dave Bridges
YZYanling Zhang
Yanling Zhang
WLWei-Wei Lee
Wei-Wei Lee
EREllen Riehle
Ellen Riehle
LWLois S. Weisman
Lois S. Weisman
Mutations that cause defects in levels of the signaling lipid phosphatidylinositol 3,5-bisphosphate [PI(3,5)P 2 ] lead to profound neurodegeneration in mice. Moreover, mutations in human FIG4 predicted to lower PI(3,5)P 2 levels underlie Charcot–Marie–Tooth type 4J neuropathy and are present in selected cases of amyotrophic lateral sclerosis. In yeast and mammals, PI(3,5)P 2 is generated by a protein complex that includes the lipid kinase Fab1/Pikfyve, the scaffolding protein Vac14, and the lipid phosphatase Fig4. Fibroblasts cultured from Vac14 −/− and Fig4 −/− mouse mutants have a 50% reduction in the levels of PI(3,5)P 2 , suggesting that there may be PIKfyve-independent pathways that generate this lipid. Here, we characterize a Pikfyve gene-trap mouse ( Pikfyve β -geo/ β -geo ), a hypomorph with ∼10% of the normal level of Pikfyve protein. shRNA silencing of the residual Pikfyve transcript in fibroblasts demonstrated that Pikfyve is required to generate all of the PI(3,5)P 2 pool. Surprisingly, Pikfyve also is responsible for nearly all of the phosphatidylinositol-5-phosphate (PI5P) pool. We show that PI5P is generated directly from PI(3,5)P 2 , likely via 3′-phosphatase activity. Analysis of tissues from the Pikfyve β -geo/ β -geo mouse mutants reveals that Pikfyve is critical in neural tissues, heart, lung, kidney, thymus, and spleen. Thus, PI(3,5)P 2 and PI5P have major roles in multiple organs. Understanding the regulation of these lipids may provide insights into therapies for multiple diseases.

27 November 2008 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
NJNatsuko Jin
Natsuko Jin
CCClement Y Chow
Clement Y Chow
LLLi Liu
Li Liu
SZSergey N Zolov
Sergey N Zolov
RBRoderick Bronson
Roderick Bronson
LWLois S Weisman
Lois S Weisman
The signalling lipid PI(3,5)P2 is generated on endosomes and regulates retrograde traffic to the trans‐Golgi network. Physiological signals regulate rapid, transient changes in PI(3,5)P2 levels. Mutations that lower PI(3,5)P2 cause neurodegeneration in human patients and mice. The function of Vac14 in the regulation of PI(3,5)P2 was uncharacterized previously. Here, we predict that yeast and mammalian Vac14 are composed entirely of HEAT repeats and demonstrate that Vac14 exerts an effect as a scaffold for the PI(3,5)P2 regulatory complex by direct contact with the known regulators of PI(3,5)P2: Fig4, Fab1, Vac7 and Atg18. We also report that the mouse mutant ingls (infantile gliosis) results from a missense mutation in Vac14 that prevents the association of Vac14 with Fab1, generating a partial complex. Analysis of ingls and two additional mutants provides insight into the organization of the PI(3,5)P2 regulatory complex and indicates that Vac14 mediates three distinct mechanisms for the rapid interconversion of PI3P and PI(3,5)P2. Moreover, these studies show that the association of Fab1 with the complex is essential for viability in the mouse. There is a [Have you seen ...?][1] (January 2009) associated with this Article. [1]: http://dx.doi.org/10.1038/emboj.2008.270

11 March 2002 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
CBCecilia J. Bonangelino
Cecilia J. Bonangelino
JNJohnathan J. Nau
Johnathan J. Nau
JDJason E. Duex
Jason E. Duex
MBMikala Brinkman
Mikala Brinkman
AWAndrew E. Wurmser
Andrew E. Wurmser
LWLois S. Weisman
Lois S. Weisman
Phosphatidylinositol 3,5-bisphosphate (PtdIns[3,5]P2) was first identified as a nonabundant phospholipid whose levels increase in response to osmotic stress. In yeast, Fab1p catalyzes formation of PtdIns(3,5)P2 via phosphorylation of PtdIns(3)P. We have identified Vac14p, a novel vacuolar protein that regulates PtdIns(3,5)P2 synthesis by modulating Fab1p activity in both the absence and presence of osmotic stress. We find that PtdIns(3)P levels are also elevated in response to osmotic stress, yet, only the elevation of PtdIns(3,5)P2 levels are regulated by Vac14p. Under basal conditions the levels of PtdIns(3,5)P2 are 18–28-fold lower than the levels of PtdIns(3)P, PtdIns(4)P, and PtdIns(4,5)P2. After a 10 min exposure to hyperosmotic stress the levels of PtdIns(3,5)P2 rise 20-fold, bringing it to a cellular concentration that is similar to the other phosphoinositides. This suggests that PtdIns(3,5)P2 plays a major role in osmotic stress, perhaps via regulation of vacuolar volume. In fact, during hyperosmotic stress the vacuole morphology of wild-type cells changes dramatically, to smaller, more highly fragmented vacuoles, whereas mutants unable to synthesize PtdIns(3,5)P2 continue to maintain a single large vacuole. These findings demonstrate that Vac14p regulates the levels of PtdIns(3,5)P2 and provide insight into why PtdIns(3,5)P2 levels rise in response to osmotic stress.